Lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized study comparing 750-rad treatment with 2,000-rad treatment
Twenty patients with intractable rheumatoid arthritis were treated with 750-rad or 2,000-rad lymphoid irradiation in a randomized double-blind comparative study. Over a 12-month followup period, there was a significant improvement in 4 of 7 and 6 of 7 standard parameters of disease activity following treatment with 750 rads and 2,000 rads, respectively. Transient, short-term toxicity was less frequent with the lower dose. In both groups, there was a sustained peripheral blood lymphopenia, a selective depletion of T helper (Leu-3a+) lymphocytes, and reduced in vitro mitogen responses. These changes did not occur, however, in synovial fluid. These results suggest that 750-rad lymphoid irradiation is as effective as, but less toxic than, that with 2,000 rads in the management of patients with intractable rheumatoid arthritis.
- Research Organization:
- St. Vincent's Hospital, Dublin, Ireland
- OSTI ID:
- 5730767
- Journal Information:
- Arthritis Rheum.; (United States), Vol. 1
- Country of Publication:
- United States
- Language:
- English
Similar Records
Sustained improvement of intractable rheumatoid arthritis after total lymphoid irradiation
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
RHEUMATIC DISEASES
RADIOTHERAPY
DOSE-RESPONSE RELATIONSHIPS
LYMPHATIC SYSTEM
LYMPHOCYTES
PATIENTS
SIDE EFFECTS
ANIMAL CELLS
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BODY FLUIDS
CONNECTIVE TISSUE CELLS
DISEASES
LEUKOCYTES
MATERIALS
MEDICINE
NUCLEAR MEDICINE
RADIOLOGY
SKELETAL DISEASES
SOMATIC CELLS
THERAPY
560151* - Radiation Effects on Animals- Man
550603 - Medicine- External Radiation in Therapy- (1980-)